test 4 part 2 Flashcards
Adrenergic receptor locations
- effector organ from adrenal medulla
- NE from post synaptic symp neuron on effector organ
Sympathetic Nervous System
Norepinephrine (Noradrenaline)
Primary neurotransmitter released by adrenergic
neurons
CNS
Sympathetic nervous system
Epinephrine (Adrenaline)
Released from adrenal medulla as a hormone
adrenal medulla releases
- 80% epinephrine
- 20% NE
Sympathomimetics
-mimic sympathetic NS
Drugs that activate adrenergic receptors
Direct-acting agonists
Indirect-acting agonists (effect amount of NE present)
Sympatholytics
Drugs that block the activation of adrenergic receptors
Adrenergic Neurotransmission step 1
• Tyrosine is transported into neuron and hydroxylated to dihydroxyphenylalanine (DOPA) by tyrosine hydroxylase
• DOPA is decarboxylated into dopamine in the presynaptic neuron
-hydroxylation of tyrosine is the rate-limiting step
Adrenergic Neurotransmission step 2
• Dopamine transported into vesicles by amine transporter system
• Dopamine is hydroxylated to Norepinephrine by dopamine β-hydroxylase
-takes place inside the vessicle
Adrenergic Neurotransmission step 3
- Action potential arrival triggers influx of Calcium ions
- Synaptic vesicles fuse with cell membrane
- Exocytosis releases contents into synapse
Adrenergic Neurotransmission step 4
- NE binds to postsynaptic receptors on effector organ (or to autoreceptors on nerve ending)
- Metabotropic receptors trigger cascade of events within the cell
- Intracellular second messengers transduce the signal
Adrenergic Neurotransmission step 5
• Norepinephrine is removed from synaptic space
1. Diffuses out 2. Is taken back into neuron 3. Metabolized by catechol-O- methyltransferase (COMT) in the synaptic space
Adrenergic Neurotransmission step 6
• Norepinephrine is
1. Taken up into synaptic vesicles
2. Persists in cytosol
OR
3. Oxidized by monoamine oxidase (MAO)
Adrenoreceptors
Two main families (α and β) classified by their affinities for norepinephrine, epinephrine, and isoproterenol (a direct acting synthetic catecholamine)
α-Adrenoreceptors
Potency and affinity
-Affinity:
epinephrine > norepinephrine»_space; isoproterenol
α-Adrenoreceptors
Subdivided into 2 groups based on their affinities for α agonists and antagonists
α1 – relatively high affinity for phenylephrine
α2 - relatively high affinity for the anti-hypertensive drug clonidine
α1
Postsynaptic membrane of effector organs
Mediate many classic adrenergic effects of smooth muscle (constriction)
Activates G proteins to form second messengers
DAG: turns on other intracellular proteins
IP3: initiates release of calcium from endoplasmic reticulum into cytosol
α1 Effect
- agonist binds causing the GDP to fall off and GTP to bind to the alpha subunit
- disassociates and activates phospholipase C
- Phospholipase C then uses second messengers DAG and IP3 leading to an increase in intracellular Ca++
What happens when you stimulate an α1 receptor
Increased vascular tone → increased SVR → increased blood pressure
Mydriasis (pupils dilate)
Increased bladder tone
Increased tension in prostate
α1 Logic
Think… “Fight or Flight”
You want an increase in blood pressure
You want to take in as much light as possible
You don’t want to stop and urinate
α2
Primarily on sympathetic presynaptic nerve endings
Also found on parasympathetic presynaptic nerve endings
Control release of norepinephrine: inhibitory autoreceptors- create negative feedback loops
Effect mediated by inhibition of adenylyl cyclase and decrease in cAMP
α2 Effect
-activation of alpha 2 receptor decreases production of cAMP leading to an inhibition of further release of nerepinephrine from the neuron
What happens when you stimulate an α2 receptor
Inhibition of norepinephrine release Inhibition of sympathetic tone in vasculature (decrease BP) Inhibition of ACh release Inhibition of insulin release sedative for anesthesia
α Receptors location
α1 – postsynaptic membrane of effector organ
α2 - presynaptic nerve endings
α Receptor Subdivisions
α1
further divided into A, B, C and D
α2
further divided into A, B, and C
Necessary for understanding selectivity of certain drugs
-reason we care is that we can give drugs that don’t affect all of the alpha receptors
β-Adrenoreceptors affinity
isoproterenol > epinephrine > norepinephrine
-synthetic substance, not found endogenously
β-Adrenoreceptor
Subdivided into 3 major subgroups based on affinities for β agonists and antagonists
- adrenergic receptors so they use a G protein and function via second messengers
- any time you stimulate a beta receptor you have an increase in cAMP
β-Adrenoreceptor Subtypes
β1
Equal affinity for norepinephrine and epinephrine (both much less than isoproterenol)
β2
Higher affinity for epinephrine than norepinephrine
β3
Involved in lipolysis and have effects on the muscle of the bladder
The heart contains predominately
β1 receptors
What happens when you stimulate a β1 receptor
Tachycardia
Increased myocardial contractility
Increased renin release from kidneys (increase BP)
Increased lipolysis
β1 Logic
Heart beats harder and faster to deliver more blood to skeletal muscle
More triglycerides for energy
Increased blood pressure for increased tissue perfusion
β2 found mostly where
- in the lungs
What happens when you stimulate a β2 receptor
Relaxation of pulmonary smooth muscle Vasodilation of skeletal muscle Decreased PVR Increased glucagon release Uterine muscle relaxation
β2 Logic
Airways open for more oxygen
More blood flow to skeletal muscle
More glucagon for energy
α1 mostly affects
vasculature
α2 mostly affects
CNS feedback loops to treat HTN and provide sedation
β1 mostly affects
the heart
β2 mostly affects
the lungs
Dopaminergic Receptors
5 subtypes exist
D1 and D2
in peripheral mesenteric and renal vascular beds
D2 on presynaptic adrenergic neurons
Dopamine can affect all other adrenergic receptors
Main sites of action of dopamine
Brain
Renal and visceral arterioles
Cardiovascular system
-G protein receptors
-interfere with release of NE
Dopamine Logic
Renal
Vasodilation
Natriuresis
Cardiac
Activates β receptors of the heart and increases contractility and rate
Vascular
Can increase or decrease PVR in a dose dependent manner
Receptor Desensitization
Prolonged exposure to the catecholamines (NE, epi, and dopamine) reduces the responsiveness of the receptors
Sequestration of receptors (become unavailable for binding)
Down-regulation
Phosphorylation of receptor – inability to couple G protein